Early intervention in oral health can lead to significant cost savings, particularly in managing chronic conditions like diabetes.
In this episode, two innovative leaders revolutionizing the oral healthcare industry, Dr. Tina Saw, CEO of Oral Genome, and Brian Jones, the Chief Growth Officer of Avēsis, highlight their partnership, which aims to deliver better healthcare outcomes for vulnerable populations, including Medicaid recipients. Together, they are transforming oral health by identifying early signs of serious health issues like diabetes through innovative, accessible technology. Their collaboration focuses on scaling these solutions within the existing healthcare structures, ensuring early intervention and cost-effective care. Dr. Saw and Brian also touch on the hurdles they faced, the integration of new technology, and their commitment to pushing boundaries in healthcare.
Tune in and learn how bold thinking and strategic partnerships are making a real difference in oral and overall health!
Resources:
Outcomes Rocket